• NEJM publishes second successful Epidiolex trial in LGS pharmatimes
    July 12, 2018
    The New England Journal of Medicine has published the second of two late stage studies showing that GW Pharma’s cannabinoid Epidiolex cut seizures in patients with the rare childhood epilepsy Lennox-Gastaut Syndrome.
PharmaSources Customer Service